Other Controls and Reagents
Immunoassay Testing
(735)
Lipid Controls
(669)
General Chemistry Testing and Controls
(494)
Quality Control Testing Slides
(260)
Blood Bank Reagents
(135)
Glucose Controls
(103)
Search Within Results
2,116
–
2,130
of
2,729
results
2,116
Medchemexpress LLC Glucose-PEG2000-Cy3 | 95.0% | 10 MG
Glucose-PEG2000-Cy3 is a Cy3-labeled glucose-PEG conjugate designed for fluorescent labeling and delivery studies. The Cy3 fluorophore enables visible-range fluorescence detection, while the glucose-PEG2000 moiety promotes cellular uptake and can reduce endosomal degradation.
- Cy3 fluorophore with emission maximum around 562-570 nm.
- Peg2000 average molecular weight ~2000.
- Purity typically 95.0% (by HPLC).
- Suitable for immunolabeling, nucleic acid labeling, fluorescence microscopy, and flow cytometry.
- Appearance: pale purple to purple oil.
- Store protected from light; in solvent store at -80°C (6 months) or -20°C (1 month).
2,117
Avanti Polar Lipids 26,26,26,27,27,27-hexadeuteriolanosta-8,24-dien-3ß-ol, 28290-39-3, 1 mg
Molecular Formula: C30H44D6O, Formula Weight: 432.754, Purity >99%.
2,118
Medchemexpress LLC Butanoic acid, 4-(dimethylamino)-, (10Z,13Z)-1-(9Z,12Z)-9,12-octadecadien-1-yl-10,13-nonadecadien... | 1224606-06-7 | 99.9% | 642.09 | 500 MG
D-Lin-MC3-DMA is an ionizable cationic lipid that serves as a potent siRNA delivery vehicle. It is intended for research use only and not for sale to patients.
- Potent siRNA delivery vehicle.
- Exhibits an optimized pKa value that leads to dramatically enhanced potency in vivo when formulated in lipid nanoparticles (LNPs) for siRNA delivery.
- Can be formulated into lipid nanoparticles with specific molar ratios for siRNA targeting transthyretin (TTR) mRNA.
- LNP-siRNA systems containing D-Lin-MC3-DMA optimize gene silencing potency in hepatocytes following IV administration in mice.
- Available in various quantities and solution formats.
2,119
Avanti Polar Lipids C18(plasm)-18:1(d9) PC | 2315262-03-2 | 1mg
C18(plasm)-18:1(d9) PC | Putity: >99% | MW: 781.19 | 2315262-03-2 | 1mg
2,120
Avanti Polar Lipids COAGULATION REAGENT 200MG
Coagulation Reagent I, contains DOPE:DOPS:DOPC; 200mg(2x100mg); Avanti mfg# 790304P-200mg
2,121
2,122
2,123
2,124
2,125
2,126
2,127
2,128
2,129
2,130